Discussion The current study is the first to evaluate the use of both oral and subcutaneous semaglutide in the same real-world clinical practice
The common thread is ineligibility for the manufacturer savings card, making the $1,430-$1,650 price the starting point for cost conversations
But these current anti-obesity medications may start turning things around, as more physicians are willing to prescribe them, and more patients are eager to ask for them
GLP-1 agonists are generally well tolerated with GI side effects such as nausea, vomiting, and diarrhea predominating
doi: 10.1016/j.clinbiochem.2012.10.006 16 MaebashiMKawamuraNSatoMImamuraAYoshinagaK
Further details regarding the statistical analyses performed are provided in ESM Appendix 3 and ESM Fig